Eledon Pharmaceuticals Inc. (ELDN)
NASDAQ: ELDNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ELDN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $196.65M
- EPS (TTM)
- -$0.89
- Dividend yield
- None
- 52-week range
- 1.35 – 4.60
- Day range
- 2.39 – 2.48
- Volume / Avg
- 581.21K / 949.99K
- Beta
- —
- Shares outstanding
- 81.26M
- Next earnings
- Nov 13, 2026
52-week range
ELDN stock today
On Oct 7, ELDN ended the session at $2.42, shedding $0.03 (1.22%), versus the S&P 500's 0.22% decline. Shares are 47.4% below their 52-week high of $4.60, set on Nov 3, 2025 and 79.3% above the 52-week low of $1.35, in the middle of the past year's range. ELDN is up 60.3% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 11.4%.
Eledon Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$0.89), so its P/E ratio is not meaningful. Eledon Pharmaceuticals's next earnings report is expected on Nov 13, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Eledon Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2014
Earnings
Earnings history- Next report
- Nov 13, 2026
Eledon Pharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RNACCartesian Therapeutics Inc. | 6.68 | -1.04% | $202.11M | vs ELDN |
| WHWKWhitehawk Therapeutics Inc. | 3.41 | -5.54% | $194.40M | vs ELDN |
| ADAGAdagene Inc. ADR | 2.81 | -4.10% | $188.67M | vs ELDN |
| LYELLyell Immunopharma Inc. | 8.56 | -0.58% | $209.76M | vs ELDN |
| NGENNervGen Pharma Corp. | 1.74 | -0.57% | $187.09M | vs ELDN |
| ANTXAN2 Therapeutics Inc. | 4.85 | -4.34% | $183.02M | vs ELDN |
| ORMPOramed Pharmaceuticals Inc. | 4.37 | -0.23% | $181.78M | vs ELDN |
| ADCTADC Therapeutics SA | 1.42 | +11.81% | $181.29M | vs ELDN |
Indexes, lists and sector
Eledon Pharmaceuticals stock FAQ
What is Eledon Pharmaceuticals's stock price today?
ELDN last traded at $2.42 as of Oct 7, 4:00 PM EDT, down 1.22% on the day. Prices are delayed at least 15 minutes.
Does Eledon Pharmaceuticals pay a dividend?
No. Eledon Pharmaceuticals does not currently pay a regular cash dividend.
When is Eledon Pharmaceuticals's next earnings date?
Eledon Pharmaceuticals is expected to report earnings on Friday, November 13, 2026.
Has ELDN ever split its stock?
Yes. The most recent ELDN stock split was a 1-for-18 split on Oct 5, 2020, one of 2 splits on record.
What is the ELDN 52-week high?
The 52-week high for ELDN is $4.60 and the 52-week low is $1.35. The stock is currently 47.4% below its high.